Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Patent: 7,847,068

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 7,847,068
Title:Neutralizing human anti-IGFR antibody
Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
Inventor(s): Wang; Yan (Scotch Plains, NJ), Greenberg; Robert (Sparta, NJ), Presta; Leonard (San Francisco, CA), Pachter; Jonathan A. (Setauket, NY), Hailey; Judith (Edison, NJ), Brams; Peter (Sacramento, CA), Williams; Denise (San Jose, CA), Srinivasan; Mohan (Cupertino, CA), Feingersh; Diane (Union City, CA)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:11/598,520
Patent Claims:see list of patent claims

Details for Patent 7,847,068

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. RITUXAN rituximab Injection 103705 1997-11-26 ⤷  Try it Free 2022-05-24
Idec Pharmaceuticals Corp. RITUXAN rituximab Injection 103737 2002-02-19 ⤷  Try it Free 2022-05-24
Eisai, Incorporated ONTAK denileukin diftitox Injection 103767 1999-02-05 ⤷  Try it Free 2022-05-24
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 1998-09-25 ⤷  Try it Free 2022-05-24
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 2017-02-10 ⤷  Try it Free 2022-05-24
Genentech, Inc. RITUXAN HYCELA rituximab and hyaluronidase human Injection 761064 2017-06-22 ⤷  Try it Free 2022-05-24
Genentech, Inc. HERCEPTIN HYLECTA trastuzumab and hyaluronidase-oysk Injection 761106 2019-02-28 ⤷  Try it Free 2022-05-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.